Maternal serum ischemia-modified albumin as an oxidative stress biomarker in preterm pre-labor rupture of membranes
Open Access
- 30 September 2024
- journal article
- research article
- Published by VM Media Group sp. z o.o in Ginekologia Polska
- Vol. 95 (9) , 705-710
Abstract
Objectives: To evaluate the maternal serum ischemia-modified albumin (IMA) concentration as an oxidative stress biomarker in pregnancies complicated by preterm pre-labor rupture of membranes (PPROM) without maternal clinical infection and compare these results with healthy pregnancies. Material and methods: The present cohort study included 40 pregnancies complicated by PPROM and 49 similar gestational age healthy pregnancies in the third trimester of gestation. Maternal venous blood specimens were obtained at the day of first diagnosis. Maternal serum IMA level was assayed with an Albumin Cobalt Binding test. The subjects were followed up until delivery and perinatal outcomes were recorded. Results: The maternal serum IMA concentrations were significantly higher in the study group (0.56 ± 0.05 absorbance units) as compared to controls (0.54 ± 0.03 absorbance units) (p = 0.020). The maternal serum IMA concentrations were not significantly correlated with the initial maternal white blood cell count (r: 0.118, p = 0.269) and C-reactive protein levels (r: 0.066, p = 0.541). The maternal serum IMA concentrations were negatively correlated with gestational age at delivery (r: –0.248, p = 0.019), birthweight (r: –0.247, p = 0.020) and Apgar scores (r: –0.200, p = 0.049; r: –0.245, p = 0.020). The threshold value of maternal serum IMA concentration above 0.55 absorbance units indicated the pregnancy complicated by PPROM by 57.5% sensitivity and 57.1% specificity (Area under curve 0.613, confidence interval 0.50–0.73). Conclusions: The current study supported for the first time that there is an association between increased maternal serum IMA levels and the development of PPROM in the third trimester of gestation without maternal clinical infection. Elevated maternal serum IMA levels may alert the obstetrician about poor ongoing perinatal outcomes in the early phase of PPROM before increased maternal C-reactive protein and white blood cell count. Objectives: To evaluate the maternal serum ischemia-modified albumin (IMA) concentration as an oxidative stress biomarker in pregnancies complicated by preterm pre-labor rupture of membranes (PPROM) without maternal clinical infection and compare these results with healthy pregnancies. Material and methods: The present cohort study included 40 pregnancies complicated by PPROM and 49 similar gestational age healthy pregnancies in the third trimester of gestation. Maternal venous blood specimens were obtained at the day of first diagnosis. Maternal serum IMA level was assayed with an Albumin Cobalt Binding test. The subjects were followed up until delivery and perinatal outcomes were recorded. Results: The maternal serum IMA concentrations were significantly higher in the study group (0.56 ± 0.05 absorbance units) as compared to controls (0.54 ± 0.03 absorbance units) (p = 0.020). The maternal serum IMA concentrations were not significantly correlated with the initial maternal white blood cell count (r: 0.118, p = 0.269) and C-reactive protein levels (r: 0.066, p = 0.541). The maternal serum IMA concentrations were negatively correlated with gestational age at delivery (r: –0.248, p = 0.019), birthweight (r: –0.247, p = 0.020) and Apgar scores (r: –0.200, p = 0.049; r: –0.245, p = 0.020). The threshold value of maternal serum IMA concentration above 0.55 absorbance units indicated the pregnancy complicated by PPROM by 57.5% sensitivity and 57.1% specificity (Area under curve 0.613, confidence interval 0.50–0.73). Conclusions: The current study supported for the first time that there is an association between increased maternal serum IMA levels and the development of PPROM in the third trimester of gestation without maternal clinical infection. Elevated maternal serum IMA levels may alert the obstetrician about poor ongoing perinatal outcomes in the early phase of PPROM before increased maternal C-reactive protein and white blood cell count.Keywords
This publication has 20 references indexed in Scilit:
- Expression of 8-oxoguanine Glycosylase in Human Fetal MembranesAmerican Journal of Reproductive Immunology, 2014
- Short Fetal Leukocyte Telomere Length and Preterm Prelabor Rupture of the MembranesPLOS ONE, 2012
- The antibiotic treatment of PPROM study: systemic maternal and fetal markers and perinatal outcomesAmerican Journal of Obstetrics and Gynecology, 2012
- Assessment of ischemia-modified albumin level in patients with recurrent pregnancy loss during the first trimesterEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2011
- Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndromeThe American Journal of Emergency Medicine, 2010
- The novel ischemia marker ‘ischemia‐modified albumin’ is increased in normal pregnanciesActa Obstetricia et Gynecologica Scandinavica, 2009
- Cord Blood Ischemia‐Modified Albumin Levels in Normal and Intrauterine Growth Restricted PregnanciesMediators of Inflammation, 2008
- Association between oxidative stress in pregnancy and preterm premature rupture of membranesClinical Biochemistry, 2007
- First trimester maternal serum ischaemia-modified albumin: a marker of hypoxia-ischaemia-driven early trophoblast developmentHuman Reproduction, 2007
- Reactive Oxygen Species and Preterm Premature Rupture of Membranes—A ReviewPlacenta, 2001